Related Articles
A multi‑targeted tyrosine kinase inhibitor lenvatinib for the treatment of mice with advanced glioblastoma
Rectal ulcer associated with lenvatinib 15 years after definitive radiotherapy for prostate cancer: A case report
Efficacy and safety of proton pump inhibitors and H2 receptor antagonists in the initial non‑eradication treatment of duodenal ulcer: A network meta‑analysis
Therapeutic effects of lenvatinib in combination with rAd‑p53 for the treatment of non‑small cell lung cancer
Primary ovarian insufficiency associated with lenvatinib therapy in a patient with hepatocellular carcinoma: A case report